Membrane-based lateral flow immunochromatographic strip with nanoparticles as reporters for detection: A review

Biosensors & Bioelectronics
Xiaolin HuangYonghua Xiong

Abstract

Membrane-based lateral flow immunochromatographic strip (LFICS) is widely used in various fields because of its simplicity, rapidity (detection within 10min), and low cost. However, early designs of membrane-based LFICS for preliminary screening only provide qualitative ("yes/no" signal) or semi-quantitative results without quantitative information. These designs often suffer from low-signal intensity and poor sensitivity and are only capable of single analyte detection, not simultaneous multiple detections. The performance of existing techniques used for detection using LFICS has been considerably improved by incorporating different kinds of nanoparticles (NPs) as reporters. NPs can serve as alternative labels and improve analytical sensitivity or limit of detection of LFICS because of their unique properties, such as optical absorption, fluorescence spectra, and magnetic properties. The controlled manipulation of NPs allows simultaneous or multiple detections by using membrane-based LFICS. In this review, we discuss how colored (e.g., colloidal gold, carbon, and colloidal selenium NPs), luminescent (e.g., quantum dots, up-converting phosphor NPs, and dye-doped NPs), and magnetic NPs are integrated into membrane-based LFICS fo...Continue Reading

References

Jun 24, 1991·Journal of Immunological Methods·J K HortonM J O'Sullivan
Jan 1, 1981·Journal of Immunological Methods·J H LeuveringA H Schuurs
Dec 24, 2005·Lab on a Chip·Jing WangHaim H Bau
Aug 13, 2008·Analytical and Bioanalytical Chemistry·Geertruida A Posthuma-TrumpieAart van Amerongen
Oct 28, 2008·Journal of Immunological Methods·Maria LönnbergJan Carlsson
Apr 22, 2009·Journal of Immunological Methods·Tuomas NäreojaHarri Härmä
Jun 2, 2009·Journal of Virological Methods·Shon WorkmanTimothy C Granade
May 21, 2010·The Analyst·Feng WangXiaogang Liu
Jul 31, 2010·Nanoscale Research Letters·Hao YangDaxiang Cui
Sep 3, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Zaheer A ParpiaDavid M Kelso
Nov 9, 2010·Analytica Chimica Acta·Laura AnfossiGianfranco Giraudi
Dec 1, 2010·Chemical Communications : Chem Comm·Libing WangChuanlai Xu
Sep 10, 2011·Analytical and Bioanalytical Chemistry·Geertruida A Posthuma-TrumpieAart van Amerongen
Nov 30, 2011·Sensors and Actuators. B, Chemical·Xianbo QiuHaim H Bau
Sep 15, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Marja-Leena JärvenpääTimo Lövgren
Oct 3, 2012·PloS One·Brittany A RohrmanRebecca R Richards-Kortum
Jul 6, 2014·PLoS Neglected Tropical Diseases·Paul L A M CorstjensUNKNOWN Cysticercosis Working Group in Peru

❮ Previous
Next ❯

Citations

Sep 30, 2016·Frontiers in Microbiology·Zheng-Xin HeFu-Kun Wang
Nov 3, 2016·Tropical Medicine & International Health : TM & IH·Marc CastellarnauAlbert Picado
Oct 28, 2016·Biotechnology Journal·Laura SutarlieXiaodi Su
Feb 16, 2018·Analytical and Bioanalytical Chemistry·Tingting BaiXiang Lu
Mar 24, 2018·Chemical Society Reviews·Xiaolin HuangXiaoyuan Chen
Feb 9, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yue ZhangYan Zhao
Nov 17, 2017·Archives of Gynecology and Obstetrics·Xaveer Van OstadeGeert Van Raemdonck
Jun 3, 2020·Biomolecules·Esther Serrano-PertierraMaría Carmen Blanco-López
Dec 28, 2017·Journal of Toxicology and Environmental Health. Part a·Fan HeYudong Shen
Sep 17, 2020·Biotechnology and Applied Biochemistry·Mohammad Lukman YahayaKhairunisak Abdul Razak
Feb 23, 2017·Veterinary Research·Jasmina VidicNicole Jaffrezic-Renault
Feb 1, 2019·Sensors·Delyan R HristovKimberly Hamad-Schifferli
Feb 23, 2020·Beilstein Journal of Nanotechnology·María Sanromán Iglesias, Marek Grzelczak
Apr 23, 2020·Journal of Nanobiotechnology·Congli TangNongyue He
Sep 24, 2020·World Journal of Microbiology & Biotechnology·Feng ShiChuangfu Chen
Oct 19, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Yue ZhangYan Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.